BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36826594)

  • 1. Dissecting the inflammatory tumor microenvironment of esophageal adenocarcinoma: mast cells and natural killer cells are favorable prognostic factors and associated with less extensive disease.
    Dos Santos Cunha AC; Simon AG; Zander T; Buettner R; Bruns CJ; Schroeder W; Gebauer F; Quaas A
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):6917-6929. PubMed ID: 36826594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.
    Huai Q; Guo W; Han L; Kong D; Zhao L; Song P; Peng Y; Gao S
    Transl Cancer Res; 2021 Apr; 10(4):1787-1803. PubMed ID: 35116502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.
    Strizova Z; Snajdauf M; Stakheev D; Taborska P; Vachtenheim J; Biskup J; Lischke R; Bartunkova J; Smrz D
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):1979-1992. PubMed ID: 32447483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients.
    Xu B; Chen L; Li J; Zheng X; Shi L; Wu C; Jiang J
    Oncotarget; 2016 Nov; 7(46):74904-74916. PubMed ID: 27736796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor infiltrative growth pattern correlates with the immune microenvironment and is an independent factor for lymph node metastasis and prognosis in stage T1 esophageal squamous cell carcinoma.
    Zhao Y; Xu E; Yang X; Zhang Y; Chen H; Wang Y; Jin M
    Virchows Arch; 2020 Sep; 477(3):401-408. PubMed ID: 32232560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma.
    Yakirevich E; Lu S; Allen D; Mangray S; Fanion JR; Lombardo KA; Safran H; Resnick MB
    Hum Pathol; 2017 Aug; 66():126-135. PubMed ID: 28666927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic profiling and prognostic significance of immune infiltrates in esophageal squamous cell carcinoma.
    Pan C; Wang Y; Liu Q; Hu Y; Fu J; Xie X; Zhang S; Xi M; Wen J
    Oncoimmunology; 2021 Feb; 10(1):1883890. PubMed ID: 33628625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.
    Landau MS; Hastings SM; Foxwell TJ; Luketich JD; Nason KS; Davison JM
    Mod Pathol; 2014 Dec; 27(12):1578-89. PubMed ID: 24762549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor immune microenvironment in therapy-naive esophageal adenocarcinoma could predict the nodal status.
    Kotsafti A; Fassan M; Cavallin F; Angerilli V; Saadeh L; Cagol M; Alfieri R; Pilati P; Castoro C; Castagliuolo I; Scarpa M; Scarpa M
    Cancer Med; 2023 Mar; 12(5):5526-5535. PubMed ID: 36281585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
    Pan L; Zhang Y; Gao Y; Qiu J
    Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.
    Harada K; Hwang H; Wang X; Abdelhakeem A; Iwatsuki M; Murphy MAB; Maru DM; Weston B; Lee JH; Rogers JE; Trail A; Shanbhag N; Zhao M; Bhutani MS; Nguyen QN; Swisher SG; Ikoma N; Das P; Hofstetter WL; Badgwell BD; Ajani JA
    Gastric Cancer; 2020 Sep; 23(5):904-912. PubMed ID: 32347396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
    Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
    J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
    Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
    Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Novel Tumor Microenvironment-Related Prognostic Gene AIF1 May Influence Immune Infiltrates and is Correlated with TIGIT in Esophageal Cancer.
    Xu X; Wang D; Li N; Sheng J; Xie M; Zhou Z; Cheng G; Fan Y
    Ann Surg Oncol; 2022 May; 29(5):2930-2940. PubMed ID: 34751872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients.
    Jia Y; Wang H; Wang Y; Wang T; Wang M; Ma M; Duan Y; Meng X; Liu L
    Int J Cancer; 2015 Sep; 137(5):1095-106. PubMed ID: 25683635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral microbiome impacts immune infiltrates in tumor microenvironment and predicts prognosis in esophageal squamous cell carcinoma patients.
    Zhang S; Zhang S; Ma X; Zhan J; Pan C; Zhang H; Xie X; Wen J; Xie X
    Front Cell Infect Microbiol; 2023; 13():1165790. PubMed ID: 37180444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress genes in patients with esophageal squamous cell carcinoma: construction of a novel prognostic signature and characterization of tumor microenvironment infiltration.
    Liu W; Yang HS; Zheng SY; Luo HH; Feng YF; Lei YY
    BMC Bioinformatics; 2022 Sep; 23(1):406. PubMed ID: 36180848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.
    Schneider PM; Baldus SE; Metzger R; Kocher M; Bongartz R; Bollschweiler E; Schaefer H; Thiele J; Dienes HP; Mueller RP; Hoelscher AH
    Ann Surg; 2005 Nov; 242(5):684-92. PubMed ID: 16244542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune microenvironment in Barrett's esophagus adjacent to esophageal adenocarcinoma: possible influence of adjacent mucosa on cancer development and progression.
    Gokon Y; Fujishima F; Taniyama Y; Ishida H; Yamagata T; Sawai T; Uzuki M; Ichikawa H; Itakura Y; Takahashi K; Yajima N; Hagiwara M; Nishida A; Ozawa Y; Sakuma T; Kanba R; Sakamoto K; Zuguchi M; Saito M; Kamei T; Sasano H
    Virchows Arch; 2020 Dec; 477(6):825-834. PubMed ID: 32533341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.
    Glickman JN; Torres C; Wang HH; Turner JR; Shahsafaei A; Richards WG; Sugarbaker DJ; Odze RD
    Cancer; 1999 Feb; 85(4):769-78. PubMed ID: 10091753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.